$90 a share on COVID ARDS Authorization ?, page-228

Just for my own peace of mind can we confirm factually that our cells are good for a treatment in covid ards .I'm hearing (from the knockers ) that as a treatment they may be to expensive and required to be given before the symptoms are to bad, which a lot of people receiving them may not need . Then they are not effective on over 65's which are the main group for death and ventilation .If this is correct are we expecting to much for the cells as a preferred treatment of covid ards when the standard of care has seen a big reduction in deaths from covid ards and now the majority of deaths are over 65's .There are also a number of treatments coming out . I know non covid ards is a still a big market . Can any one give thoughts on the above as a discussion i'd just like some clarity ..